Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Stein

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|October 20, 2022
Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience reviewJeffrey Y C Wong, An Liu, Chunhui Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter StudyGiovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
British Journal of Haematology|April 1, 2024
Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancerHoda Pourhassan, Jianying Zhang, Jose Tinajero, et al.
British Journal of Haematology|November 6, 2024
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomesJose Tinajero, Sharon Xu, Dat Ngo, et al.
American Journal of Hematology|September 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease BurdenJose Tinajero, Kim Nguyen, Dat Ngo, et al.
Research Square|April 27, 2026
AI-Driven Bone and Marrow Segmentation on FLT-PET/CT: Technical Multi-organ Validation in AML and HCTMalakeh Malekzadeh, Hemendra Ghimire, Karteek Popuri, et al.
Leukemia & Lymphoma|December 9, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantationAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
Leukemia & Lymphoma|July 4, 2020
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemiaNicola Gökbuget, Gerhard Zugmaier, Hervé Dombret, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2011
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303Steven M Devine, Shelly Carter, Robert J Soiffer, et al.
Leukemia & Lymphoma|April 17, 2024
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot studyIbrahim Aldoss, Jianying Zhang, Marjorie Robbins, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|October 20, 2022
Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience reviewJeffrey Y C Wong, An Liu, Chunhui Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter StudyGiovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
British Journal of Haematology|April 1, 2024
Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancerHoda Pourhassan, Jianying Zhang, Jose Tinajero, et al.
British Journal of Haematology|November 6, 2024
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomesJose Tinajero, Sharon Xu, Dat Ngo, et al.
American Journal of Hematology|September 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease BurdenJose Tinajero, Kim Nguyen, Dat Ngo, et al.
Research Square|April 27, 2026
AI-Driven Bone and Marrow Segmentation on FLT-PET/CT: Technical Multi-organ Validation in AML and HCTMalakeh Malekzadeh, Hemendra Ghimire, Karteek Popuri, et al.
Leukemia & Lymphoma|December 9, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantationAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
Leukemia & Lymphoma|July 4, 2020
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemiaNicola Gökbuget, Gerhard Zugmaier, Hervé Dombret, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2011
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303Steven M Devine, Shelly Carter, Robert J Soiffer, et al.
Leukemia & Lymphoma|April 17, 2024
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot studyIbrahim Aldoss, Jianying Zhang, Marjorie Robbins, et al.
Pageof 12